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Abstract
Gene variants that disrupt T cell receptor signaling can cause severe immune deficiency, yet less 
disruptive variants are sometimes associated with immune pathology. Null mutations of the gene 
encoding the scaffold protein SLP-76, for example, cause an arrest of T cell positive selection, 
while a synthetic membrane-targeted allele allows limited positive selection but is associated with 
proinflammatory cytokine production and autoantibodies. Whether these and other enigmatic 
outcomes are due to a biochemical uncoupling of tolerogenic signaling, or simply a quantitative 
reduction of protein activity, remains to be determined. We describe here a splice variant of Lcp2 
that reduced the amount of wild-type SLP-76 protein by ~90%, disrupting immunogenic and 
tolerogenic pathways to different degrees. Mutant mice produced excessive amounts of 
proinflammatory cytokines, autoantibodies and IgE, revealing that simple quantitative reductions 
of SLP-76 were sufficient to trigger immune dysregulation. This allele reveals a dose-sensitive 
threshold for SLP-76 in the balance of immunity and immune dysregulation: a common 
disturbance of atypical clinical immune deficiencies.
Keywords
T Cell Receptor; Tolerance; Immunodeficiency Diseases; Autoimmunity
2Address correspondence to: Owen M. Siggs, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK, T: 
+44(0)1865287793, F: +44(0)1865287787, owen.siggs@sanger.ac.uk or Christopher C. Goodnow, Department of Immunology, John 
Curtin School of Medical Research, GPO BOX 334, Canberra City ACT 2601, Australia, T: +61(0)261252596, F: +61(0)261252595, 
chris.goodnow@anu.edu.au.
1O.M.S., L.A.M. and S.R.D. contributed equally to this work.
HHS Public Access
Author manuscript
J Immunol. Author manuscript; available in PMC 2015 September 15.
Published in final edited form as:
J Immunol. 2015 March 15; 194(6): 2587–2595. doi:10.4049/jimmunol.1400326.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Introduction
Exome sequencing has revealed that our protein coding genomes are spectacularly diverse, 
with new variants emerging in every generation (1). Many of these variants have no effect 
on the proteins they encode, while others inactivate them completely. The remainder fall 
between these two extremes, and lead instead to qualitative or quantitative effects on protein 
function. In the context of the immune system, we have learned a great deal from the study 
of null alleles in mice, and continue to do so with the rapid expansion and systematic 
phenotyping of public knockout mouse resources (2). Yet we understand far less about 
variants with intermediate effects, despite their frequency and capacity to cause or modify 
human disease.
Antigen recognition by the T cell receptor is a case in point, where null alleles in mice and 
humans have allowed a fine dissection of the pathway (3). Absence of the proximal kinase 
ZAP-70, for example, disrupts thymic positive selection and peripheral T cell activation, 
leading to severe immune deficiency in mice and in humans (4–7). More enigmatic is the 
outcome of missense variation in ZAP-70, which in several cases displays paradoxical 
associations between immune deficiency and autoimmune pathology (8, 9). The 
Zap70W163C variant in mouse, for example, impairs TCR signaling and positive selection, 
yet in the correct genetic and environmental context will cause autoimmune arthritis (8, 10). 
The use of an allelic series of hypomorphic Zap70 variants has established that immune 
dysregulation can result from stepwise reductions in ZAP-70 activity (9, 11–14), likely due 
to its differential contribution to immunity versus tolerance. As another example, deficiency 
of the transmembrane adapter protein LAT blocks T cell development in mice (15), yet 
missense mutations that prevent binding of phospholipase C-γ1 (LATY136F) or Grb2 and 
Grap (LATY175/195/236F) lead to lymphoproliferative disorders (16–18) dependent in the 
former case on RasGRP1-ERK signaling (19). These alleles collectively illustrate that both 
biochemical separation of function and quantitative loss of function mutations in a single 
pathway can lead to similar pathological outcomes (20).
A third critical node of proximal TCR signaling is controlled by the adapter protein SLP-76 
(21), encoded in mice by the Lcp2 gene. Null alleles of Lcp2 prevent T cell development at 
an equivalent stage to LAT (22, 23), while a synthetic membrane-targeted version is 
associated with inflammatory cytokine production and autoantibodies (24). It is not clear if 
this association is the result of a biochemical separation or acquisition of function in 
SLP-76, or if it is due to a form of quantitative reduction in function similar to ZAP-70 (9).
Here we describe a splice variant of Lcp2 that reduced the quantity of wild-type SLP-76 
protein by approximately 90%. Homozygous mutants displayed a partial block in thymocyte 
development, with further impairments in negative selection and regulatory T cell 
development. Mutant mice developed spontaneous TH1-biased effector T cells, 
accompanied by autoantibodies and elevated IgE and IgG1. The physiological outcomes of 
this mutation establish SLP-76 as a dose-sensitive node in the balance between immunity 
and immune dysregulation.
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Materials & Methods
Mice
The Lcp2twimp strain (MGI:3614800) was generated from a C57BL/6 male that received 
three weekly doses of 100 mg/kg N-ethyl-N-nitrosourea. Mutagenesis, mapping and 
sequencing methods have been described previously (25), as have 3A9 TCR transgenic (26), 
KLK4 H-2Kb:mHEL transgenic (27), NOD.H2k (28), Foxp3tm1.1Ayr (29), Foxp3tm2Ayr 
(Foxp3gfp) (30), and C57BL/6.Ly5a congenic mice. Lcp2twp/twp H2k mice were generated by 
breeding C57BL/6 Lcp2twp/twp (H2b) mice with B10.BR (H2k), and intercrossing F1 hybrids. 
Mice were housed in specific pathogen-free conditions at the Australian Phenomics Facility 
and Australian Cancer Research Facility (JCSMR), with all animal procedures approved by 
the Animal Ethics and Experimentation Committees of the Australian National University 
and University of Newcastle.
Flow cytometry
Lymphoid organ suspensions were prepared and stained with a combination of FITC-
conjugated anti-CD4 (GK1.5), anti-CD44 (IM7), anti-CD69 (H1.2F3), anti-CD3ε 
(145-2C11), anti-TCRβ (H57-597); PE-conjugated anti-CD25 (7D4), anti-GITR (DTA-1) 
and anti-CD5 (53-7.3); PerCP-conjugated anti-CD8 (53-6.7); biotinylated anti-Vβ5 
(MR9-4), anti-Vβ11 (RR3-15) and anti-TCRβ (H57-597); APC- or Qdot605-conjugated 
streptavidin; APC-conjugated anti-CD45.1 (A20) and anti-CCR7 (4B12); PE-Cy7 
conjugated anti-CD24 (M1/69) and anti-CD8 (53-6.7) and Alexa700-conjugated anti-CD4 
(GK1.5). Intracellular calcium after stimulation with anti-CD3ε (500A2) was measured 
using a mixture of Ly5-marked wild-type and mutant splenocytes labelled with Indo-1 
(Molecular Probes). In some experiments, splenocytes were stimulated for 4h at 37°C in 
complete medium containing phorbol-12-myristate-13-acetate (PMA, 50ng/mL); ionomycin 
(1μM) and Golgistop (1:1500 v/v). Intracellular staining with anti-Foxp3-FITC (FJK-16s), 
anti-IFN-γ-FITC (XMG1.2), anti-IL-4-PE (11B11), anti-IL-17A-APC (eBio17B7) and anti-
Helios-Pacific Blue (22F6) was performed using the Foxp3 Staining Buffer Set as per the 
manufacturer’s instructions (eBioscience). 3A9 TCR bearing cells were identified by 
labelling cells with the clonotype-specific 1G12 hybridoma supernatant, followed by rat 
anti-mouse IgG1-APC (A85-1).
Western blotting
Whole thymocyte lysates prepared from Lcp2+/+ and Lcp2twp/twp mice were subjected to 
SDS-PAGE, and Western blots probed with SLP-76 antiserum raised against an N-terminal 
peptide of SLP-76 (provided by G. Koretzky (31)). SLP-76 band intensity was measured by 
ImageJ.
Serology
Dilute serum (1:100) was incubated on HEp2 ANA slides (Inova), washed and incubated 
with FITC-conjugated anti-mouse IgG (Caltag). Slides were washed, mounted and 
fluorescence visualized and scored by a blinded individual. Measurement of serum 
immunoglobulins by ELISA was performed as previously described (9).
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OVA challenge model
6- to 8-week-old mice were intraperitoneally injected with 50 μg ovalbumin (OVA) and 1 
mg Rehydrogel (Reheis) in sterile saline. Mice were then challenged intranasally on days 12, 
13, 14 and 15 with 10 μg OVA under isofluorane anesthesia. Mice were sacrificed 24 hours 
following the final challenge and serum collected by cardiac puncture. IgE was captured on 
plates coated with rat anti-mouse IgE (BD Biosciences), with total IgE detected by 
biotinylated rat anti-mouse IgE (BD Biosciences) and streptavidin-HRP (Biosource), and 
OVA-specific IgE detected with biotinylated OVA and streptavidin-HRP (Biosource).
Suppression assays
Performed as previously described (32). Briefly, CTV-labeled, FACS-purified 
CD4+CD44loCD62LhiCD25− splenocytes from CD45.1 mice (“responders”) were co-
cultured for 68 hours in round-bottomed 96-well plates with or without FACS-purified 
CD3−CD4−CD8− splenocytes from Lcp2+/+ CD45.2 mice (APCs) and CD4+GFP+ 
splenocytes from Lcp2+/+ or Lcp2twp/twp CD45.2 Foxp3gfp mice (T-regs) in the presence of 
soluble anti-mouse CD3ε at 2ug/mL. At the start of the culture (day 0) each well contained 
1.8 × 104 “responders” and the responder/APC ratio was either 1:5 or 1:2, held constant 
within a given experiment, and a range of responder/T-reg ratios were used, namely 1:1, 
1:0.5 or 1:0.25 in each experiment.
Adoptive transfers
~3×107 unfractionated splenocytes were administered to 1 or 4 week-old recipient mice by 
intraperitoneal injection. Serum was collected 5–6 weeks post-transfer for the measurement 
of IgG autoantibodies, IgE and IgG1. For adoptive transfer of regulatory T cells, 
CD45.1+Foxp3−/−Rag1−/−females were bred with CD45.1 C57BL/6 males to produce 
Foxp3−/Y mice, that were injected intraperitoneally at either 1 day or 7 days after birth with 
1.25–2 × 105 FACS-sorted GFP+ splenocytes from Lcp2+/+ or Lcp2twp/twp CD45.2 Foxp3gfp 
donor mice in 40uL PBS. Recipients were analysed at 19d or 28d after birth.
Results
T cell lymphopenia associated with a splice-donor mutation in Lcp2
In a genome-wide N-ethyl-N-nitrosourea screen for regulators of lymphocyte development 
(33), we identified several related individuals from a single pedigree with reduced 
frequencies of peripheral blood T cells and increased expression of the activation marker 
CD44 (Figure 1a,b,c). This phenotype, nicknamed ‘twimp’ (twp), was inherited as a simple 
recessive Mendelian trait on a C57BL/6 background and when outcrossed to a NOD.H2k 
mapping strain (Figure 1a).
To establish the chromosomal location of the twimp mutation we outcrossed twimp males 
(C57BL/6 background) to NOD.H2k females and intercrossed the resulting F1 offspring 
(Figure 1a). From nine intercross breeder pairs, 152 offspring were screened for peripheral T 
cell deficiency and increased expression of CD44 by flow cytometry. Thirty-two individuals 
(21%) exhibited the twimp phenotype. Broad chromosomal linkage localised the mutation to 
an interval on chromosome 11, with fine mapping reducing the interval to between 
Siggs et al. Page 4
J Immunol. Author manuscript; available in PMC 2015 September 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
D11Mit230 (27.90Mb) and D11Mit296 (43.63Mb) (Figure 1d). Within this interval lay 
Lcp2: the gene encoding SLP-76 (SH2 domain-containing leukocyte phosphoprotein of 76 
kDa). Lcp2 was a strong candidate for the twimp mutation, as SLP-76-deficient mice exhibit 
severe defects in T cell development (22, 23).
After sequencing all coding exons and flanking splice junctions of Lcp2, we identified a 
single intronic base substitution between C57BL/6 wild type and twimp mice (Figure 1e). 
The T to G transversion was located four bases downstream of the conserved ‘GU/T’ 
sequence, within the intronic splice donor site of intron 12. Amplification and sequencing of 
Lcp2 cDNA from twimp splenocytes revealed the presence of both wild-type transcript and 
an aberrant transcript lacking exon 12 (Figure 1f). The absence of exon 12 is predicted to 
lead to a reading frame shift, introducing a premature termination codon within exon 13 
(Figure 1f). This was reflected by a reduction of full-length SLP-76 protein expression in 
Lcp2twp/twp thymocytes (Figure 1g), with the Western blot band intensity estimated to be 
~10% of wild-type. We detected no low molecular weight proteins using the same anti-
SLP-76 antiserum raised against amino acids 136–235 (not depicted) (31), suggesting that 
the Δe12 splice product (or any other cryptic products) were not translated.
An early and partial arrest of thymic T cell development
Lcp2twp/twp thymi were consistently of lower cellularity than wild-type littermates, with 
significantly fewer DP (CD4+CD8+), CD4SP (CD4+CD8−) and CD8SP (CD4−CD8+) cells 
compared to Lcp2+/+ controls (Figure 2a,b). Within the CD4−CD8− (double negative, DN) 
thymocyte subset, Lcp2twp/twp mice had increased proportions and total numbers of DN3 
(CD44−CD25+) cells, with fewer DN4 (CD44−CD25−) cells (Figure 2c,d), consistent with a 
defect in thymic β-selection. This partial block in T cell development was also apparent in 
the periphery, with Lcp2twp/twp mice showing reduced numbers of CD4+, but not CD8+, 
splenic T cells (Figure 2e,f).
During thymic positive selection the expression of CD5 increases, correlating positively 
with TCR signal intensity (34). Whereas CD5 expression was detectable on DP thymocytes 
from Lcp2+/+ mice, CD5 expression on thymocytes from Lcp2twp/twp mice was significantly 
lower (Figure 2g). Positive selection of DP thymocytes also leads to an increase in 
expression of CD69, TCRβ and CD3ε. Compared to wild type controls, expression of CD69, 
TCRβ and CD3ε was significantly lower on Lcp2twp/twp DP thymocytes (Figure 2g). A 
partial block of Lcp2twp/twp thymocyte development and low expression of CD5, CD69, 
TCRβ and CD3ε on DP cells was consistent with a defect in TCR signaling and reduced 
SLP-76 function. Mixed bone marrow chimeras confirmed that the T lymphocyte deficiency 
was intrinsic to Lcp2twp/twp cells, as Lcp2twp/twp T cells were at a profound competitive 
disadvantage to wild-type (not depicted), and mutant peripheral T cells also exhibited severe 
functional impairments (Hillen et al., accompanying manuscript).
Immune dysregulation
In spite of the limited development of Lcp2twp/twp T cells and their impaired activation in 
vitro, unimmunized Lcp2twp/twp mice produced significantly more IgM, IgG1, IgG2b and 
IgE than their wild-type counterparts (Figure 3a), with IgG1 and IgE being especially high 
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(Figure 3b). In the case of IgE, this did not appear to be an exaggeration of antigen-specific 
responses, since sensitisation and challenge of Lcp2twp/twp mice with ovalbumin did not 
reveal any difference in ovalbumin-specific IgE secretion (Figure 3c). Elevated serum IgE 
and IgG1 was also accompanied by IgG autoantibodies against nuclear and cytoplasmic 
antigens, which were observed in 75% of Lcp2twp/twp mice, but only 6% of wild-type 
littermates (Figure 3d). Furthermore, intracellular staining after PMA+ionomycin 
stimulation revealed an increased frequency of IFN-γ-producing CD4+ and CD8+ 
splenocytes in Lcp2twp/twp mice. While the frequency of CD4+ cells that produced IL-17A 
appeared elevated compared to wild-type, the difference was not statistically significant 
(Figure 3e).
Defective negative selection of Lcp2twp/twp T cells
TCRs with high affinity for self are normally purged from the thymocyte repertoire by 
negative selection, and defects at this stage can permit the escape of self-reactive clones that 
contribute to the onset of autoimmunity (35). To measure the efficiency of negative 
selection in Lcp2twp/twp mice, we used an in vivo model of superantigen-mediated deletion 
(36). Vβ5+ and Vβ11+ T cells that develop in the presence of the class II MHC molecule I-
Ek (encoded by the H2k haplotype) and certain endogenous mouse mammary tumor viruses 
are normally deleted in the thymus by negative selection. Yet in the absence of I-Ek (for 
example, in mice with the I-Ek-deficient H2b haplotype) these same clonotypes are not 
deleted (Figure 4a). In Lcp2twp/twp mice, Vβ5+ and Vβ11+ T cells were inefficiently deleted 
in the presence of I-Ek (Figure 4a). CD4+Vβ5+ T cells can also be deleted in an I-Ek-
independent manner (37), yet these cells were twice as prevalent in H2b Lcp2twp/twp mice 
compared to Lcp2+/+ controls (Figure 4a).
In addition to the relatively strong stimulus of superantigen-mediated deletion, we also 
measured deletion under a clonally-restricted setting using the hen egg lysozyme (HEL) 
peptide-specific 3A9 TCR transgene (class II-restricted). Positive selection was severely 
impaired in TCR transgenic Lcp2twp/twp mice, in which far fewer clonotype-positive 
(1G12+) thymocytes and splenocytes were present (Figure 4b-c). To promote negative 
selection of these cells, the 3A9 TCR transgene was combined with a class I promoter-
driven membrane-bound HEL antigen (abbreviated here as mHEL). In the presence of both 
transgenes (TCR+mHEL+), wild-type T cells are primarily deleted at the DP stage in the 
thymus, reducing DP numbers by ~99% and leaving very few clonotype-positive cells in the 
thymus or spleen (Figure 4b-c). Numbers of DP thymocytes were substantially higher in 
Lcp2twp/twp mice (Figure 4c), suggesting an impairment of negative selection. Upon closer 
examination however, the remaining DP, CD4SP and CD4+ cells did not express the 1G12-
reactive TCR transgene clonotype (Figure 4b-c), implying that negative selection was intact 
in this model.
A component of the thymocyte negative selection response that accompanies strong but not 
weak TCR signaling, and is separable from apoptosis, is upregulation of the Helios 
transcription factor (38). Using a CD24+Foxp3− gate to exclude CD24− mature thymocytes 
and Foxp3+ regulatory T cells, Lcp2twp/twp mice showed a 90% reduction in the frequency of 
TCRβ+ thymocytes, consistent with the severe defect in αβ T cell positive selection 
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described above. However, the frequency of Helios+ thymocytes within the small 
CD24+Foxp3− TCRβ+ population in Lcp2twp/twp mice was increased relative to wild-type 
(Figure 4d-e). Consistent with a requirement for TCR-signaling in upregulation of Helios, 
Zap70mrd/mrt mice analysed in parallel exhibited a decreased frequency of Helios+ cells 
within their small CD24+Foxp3−TCRβ+ thymocyte population (Figure 4d-e). These effects 
on Helios+ cell frequencies were of similar magnitude in the immature CCR7− and semi-
mature CCR7+ subsets of TCRβ+ thymocytes (data not shown). Thus, while these two 
mutations cripple both positive selection and clonal deletion in the thymus to similar 
degrees, a substantial fraction of nascent TCRβ+ Lcp2twp/twp thymocytes show evidence of 
registering a strong ZAP-70-dependent TCR signal as determined by Helios upregulation.
A second mode of thymus-acquired tolerance is the selection and activity of Foxp3+ 
regulatory T cells (39). Numbers of CD4+Foxp3+ thymocytes were reduced in Lcp2twp/twp 
mice (Figure 5a), yet splenic CD4+Foxp3+ cells were present in equivalent numbers and 
represented a greater proportion of total CD4+ cells (Figure 5b). Expression of the IL-2 
receptor alpha chain (CD25), but not the activation marker GITR, was also reduced on 
CD4+Foxp3+ splenocytes in Lcp2twp/twp mice (Figure 5c). In order to test the suppressive 
function of Lcp2twp/twp regulatory T cells, and to avoid complications of reduced CD25 
expression, we sorted CD4+GFP+ cells from wild-type and mutant Foxp3gfp reporter mice. 
After an initial experiment suggested a subtle suppression defect for Lcp2twp/twp regulatory 
T cells, we repeated the experiment using fewer APCs. Under the latter conditions of 
reduced antigen presentation, a clear defect in suppression by Lcp2twp/twp regulatory T cells 
was revealed (Figure 6a-b). Since IL-2 is critical for the survival of regulatory T cells (40), 
this reduction in CD25 expression, together with an imbalance between thymic output and 
peripheral numbers, may disrupt regulatory T cell function and contribute to dysregulated 
antibody production.
trans-acting reduction of IgE secretion in Lcp2twp/twp mice
Spontaneous production of IgE and IgG1 antibodies and IgG autoantibodies would 
commonly be suspected to arise from a dysregulation of helper T cell activity. In the case of 
Lcp2twp/twp mice, impaired negative selection may allow the persistence and activation of 
autoreactive T cells, as would a disruption of Foxp3+ regulatory T cell activity. T cell 
lymphopenia in Lcp2twp/twp mice could also contribute to T cell hyperactivity through the 
excessive provision of survival factors such as IL-7, which oppose the upregulation of pro-
apoptotic Bim by high-affinity TCR signals (41). During T cell lymphopenia IL-7 would be 
available in excess, increasing the amount of survival signal per cell and allowing the 
inappropriate survival and activation of self-reactive T lymphocytes.
To establish which of these cis- or trans-acting alternatives, if any, could explain immune 
dysregulation in Lcp2twp/twp mice, we adoptively transferred wild-type splenocytes into 
young Lcp2twp/twp recipients. Five weeks after transfer, serum IgE and IgG1 antibodies were 
both significantly reduced, indicating that a trans-acting mechanism was sufficient for the 
correction of immune dysregulation (Figure 7a).
Given their mode of action and reduced in vitro suppressive activity, we hypothesised that 
Foxp3+ cells might account for the correction of antibody secretion after adoptive transfer. 
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Transfer of splenocytes from Foxp3-deficient mice did not lead to a reduction in IgE titres 
(Figure 7b), consistent with a need for Foxp3+ regulatory T cells to suppress the excessive 
production of IgE in Lcp2twp/twp mice. However donor chimerism in the CD4+ compartment 
was also less when Foxp3-deficient splenocytes were transferred, and was negatively 
correlated with serum IgE (Figure 7c), supporting the notion that CD4+ cells were 
responsible for the trans-acting suppression of IgE. To directly test the consequences of 
adoptive transfer of Foxp3+ cells, we sorted and injected cells from Foxp3gfp reporter mice 
into Foxp3-deficient recipients. While wild-type Foxp3+ cells engrafted successfully, those 
from Lcp2twp/twp donors did not (Figure 7d). This revealed that in addition to their impaired 
suppressive function, Lcp2twp/twp regulatory T cells were also poor engrafters.
Discussion
Each of us carries an abundance of rare and common variants in protein-coding genes, but 
we know little about which of these affect protein function. We know even less about the 
physiological consequences of such variants, which can often affect biological pathways in 
unpredictable ways. TCR signaling is one such pathway (20), and our analysis here reveals 
that a purely quantitative reduction of SLP-76 protein can disrupt immunity and tolerance to 
different degrees, resulting in immune dysregulation.
The Lcp2twimp phenotype is clearly distinct from an exon 1 deletion of Lcp2 (22, 23) where 
thymic development does not progress beyond the DN3 stage. It also differs from mice with 
phenylalanine substitutions at key tyrosine residues (Y145 or Y112/128), where a predicted 
disruption of Itk (in the case of Y145F) or Vav1 regulation (in the case of Y112/128F) leads 
to less severe positive selection defects and no indication of immune dysregulation (42, 43). 
This would suggest that a simple uncoupling of Vav1 or Itk pathways cannot explain the 
Lcp2twimp phenotype, and that other qualitative or quantitative mechanisms may be 
responsible.
On the other hand, Lcp2twp/twp mice appear more similar to mice with a synthetic variant of 
SLP-76, in which the membrane-targeting sequence of LAT is fused to full-length SLP-76 
(44). Like Lcp2twp/twp, membrane-targeted SLP-76 mutants have moderate T cell 
lymphopenia and spontaneously produce autoantibodies, with peripheral T cells skewed 
towards the TH1 and TH17 lineages (24). These effects did not appear to be the result of 
skewed thymic selection, since adoptively transferred T cells from mice with a peripherally-
induced mutation also produced more pro-inflammatory cytokines. Pro-inflammatory self-
reactive T cells should also promote immune dysregulation in cis, so from our adoptive 
transfer experiments it would appear that defective negative selection was also not sufficient 
for excessive antibody production in Lcp2twp/twp mice. Nonetheless, the observation of 
defective superantigen-mediated deletion (and an increase in the frequency of Helios+ 
thymocytes) implies that the Lcp2twimp repertoire may be skewed towards higher self-
reactivity, which could in turn be a necessary (but not sufficient) factor for immune 
dysregulation.
A mechanism that may be consistent between membrane-targeted SLP-76 mutants and 
Lcp2twimp is the disrupted development and activity of Foxp3+ regulatory T cells. In both 
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instances the proportion of CD4+ cells that express Foxp3 was increased, yet expression of 
the IL-2 receptor alpha chain (CD25) was diminished. CD4+CD25+ cells from membrane-
targeted mutants were as suppressive or less suppressive than wild-type cells in vitro, 
although the combined function of all Foxp3+ cells (CD25hi and CD25lo) was not 
determined as they were in our experiments (24). IL-2 and the IL-2R alpha chain (CD25) are 
both known to be essential for peripheral regulatory T cell homeostasis (40, 45, 46), making 
reduced CD25 expression a potential contributing factor to immune dysregulation in Lcp2 
mutants.
The trans-acting suppression of antibody production in Lcp2twp/twp mice was also consistent 
with an impairment of regulatory T cell function, with Foxp3-deficient splenocytes unable to 
suppress under the same conditions. How, then, might a quantitative reduction in SLP-76 
protein disrupt regulatory T cell function? It is clear that thymic selection of CD4+Foxp3+ 
cells is dramatically reduced (perhaps due to an impairment of TCR signaling), yet their 
numbers are equivalent in the periphery. This extensive proliferative expansion from a 
limited pool of thymic emigrants may exhaust or restrict regulatory function, and might also 
account for the reduced expression of CD25 on peripheral Lcp2twp/twp Foxp3+ cells. It is 
also consistent with other findings that homeostatic expansion of Foxp3+ cells is 
independent of TCR signaling, as has been observed in mice with hypomorphic mutations in 
Zap70 (9).
This proposed mechanism appears to be distinct from other variants in TCR signaling 
associated with immune dysregulation. Zap70mrd/mrt compound heterozygotes, for example, 
develop a similar combination of elevated IgE, IgG1 and autoantibodies (9). Yet 
reconstituting mice with a mixture of Zap70mrd/mrt and wild-type fetal liver cells did not 
reduce production of IgE (9). Less clear is the role of regulatory T cells in the pathology of 
LATY136F mice: while transfer of CD4+CD25+ regulatory T cells into neonatal LATY136F 
mice could prevent pathology (47), transfer of CD4+Foxp3+ cells could not (48). 
Furthermore, LATY136F pathology does not seem to depend upon thymic selection processes 
nor an isolated loss of phospholipase C-γ1 binding, as peripheral deletion of LAT can also 
trigger lymphoproliferative disease (49). So despite falling within the same overarching 
pathway, variants of ZAP-70, LAT and SLP-76 appear to cause immune dysregulation by 
distinct mechanisms.
Immune dysregulation is not just a feature of mouse hypomorphic TCR signaling mutants, 
but is also a common characteristic of atypical human severe combined immunodeficiency 
(atypical SCID) (50). The genes mutated in atypical SCID are often the same as those in 
classical SCID (e.g. RAG1, RAG2, ADA, IL2RG, LIG4 etc.), although the mutations are 
typically hypomorphic rather than null. Partial T lymphopenia, elevated IgE, and 
autoantibodies are all observed in atypical but not classical SCID (50), consistent with their 
mouse counterparts (20). Given the mechanistic distinctions between three hypomorphic 
mutants (Zap70, Lat and Lcp2) within a common pathway (TCR signaling), it is tempting to 
speculate that the mechanisms of immune dysregulation in atypical SCID patients are more 
heterogenous still.
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Predicting the physiological effects of missense variants such as these will be a critical 
challenge for the future of human genetics. An even greater challenge will be to predict the 
effects of combinations of variants, such as compound heterozygous missense mutations at a 
single locus, or composite heterozygosity or homozygosity for several loci in a common 
pathway (51). Allelic variation in TCR signal transduction is a key illustration of this 
challenge, where hypomorphic variants at different points in the pathway can have 
paradoxical outcomes (20). Studying the effect of null alleles in mice and humans has 
defined our understanding of physiological gene function, as it has for TCR signaling, and 
will continue to do so (2). The use of mouse conditional alleles (52) and hypomorphic 
variants such as Lcp2twimp (53, 54) will complement these efforts, and play an important role 
in understanding the immunological consequences of genetic variation between wild-type 
and null.
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Figure 1. Identification and mapping of the twimp mutation
A) Initial generations of the twimp pedigree showing individuals that were affected (filled), 
unaffected (open) or not typed (cross) for the T cell phenotype. B) Definition of the twimp 
phenotype by CD4+ and CD8+ cell frequency in blood. C) Representative flow cytometry 
profiles measuring frequencies of CD4+ and CD8+ cells, and histogram overlays comparing 
expression of CD44 on CD4+ and CD8+ cells in lymph nodes. D) Fine mapping of the 
twimp mutation on chromosome 11. Haplotypes of individual twimp affected mice are 
shown in columns – C57BL/6 homozygote (black squares); C57BL/6-NOD.H2k 
heterozygote or NOD.H2k homozygote (white squares). Numbers of individual mice with 
each haplotype are indicated at the base of each column. E) Amplified genomic DNA from 
twimp mice was used to sequence Lcp2, revealing a T to G transversion within intron 12. F) 
Representative location of the twimp mutation in Lcp2, and its effect on Lcp2 RNA 
processing: sequencing of twimp cDNA revealed the presence of two transcripts: one full-
length and a second that lacked exon 12. Right hand panel shows the products of a PCR 
reaction (forward primer in exon 9, reverse in exon 13) performed on splenic cDNA from 
C57BL/6J and twimp mice. G) Schematic representation of the SLP-76 protein and the 
coding contribution of each exon, with the exon deleted in twimp (e12) shown in black. 
Expression of SLP-76 protein was measured by probing thymocyte lysates from with a 
polyclonal anti-SLP-76 antibody. SAM, sterile alpha motif; YYY, tyrosines 112/128/145; 
SH2, Src homology 2.
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Figure 2. Impaired development and function of Lcp2twp/twp T cells
A) Representative flow cytometry plots of CD4 and CD8 expression on thymocytes from 
Lcp2+/+ and Lcp2twp/twp mice, showing frequencies of each subset. B) Absolute numbers of 
DN (CD4−CD8−), DP (CD4+CD8+), CD4SP (CD4+CD8−) and CD8SP (CD4−CD8+) 
thymocytes. C) Representative flow cytometry plots of CD25 and CD44 expression on DN 
(CD4−CD8−) thymocytes from Lcp2+/+ and Lcp2twp/twp mice, resolving DN1 
(CD44+CD25−), DN2 (CD44+CD25+), DN3 (CD44−CD25+) and DN4 cells 
(CD44−CD25−). D) Absolute numbers of DN1-DN4 thymocytes. Representative flow 
cytometry plots showing percentages (E) and absolute numbers (F) of CD4+ and CD8+ 
splenic lymphocytes. G) Representative histogram overlays of CD69, CD5, TCRβ and CD3ε 
expression on DP thymocytes from Lcp2+/+ (filled, grey) and Lcp2twp/twp (open, red) 
histograms. Data are representative of (A,C,E,G) or pooled from (B,D,F) two independent 
experiments. Symbols represent individual mice, while bars represent mean and standard 
error. P values were calculated by 2-tailed unpaired Student’s t-test.
Siggs et al. Page 15
J Immunol. Author manuscript; available in PMC 2015 September 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Spontaneous immune dysregulation in Lcp2twp/twp mice
A) Relative titers of serum immunoglobulins as measured by ELISA. B) Replicated IgG1 
and IgE concentration measurements. C) Relative titres of total (left) and OVA-specific IgE 
(right). OVA/OVA groups were sensitised i.p., then challenged intranasally with ovalbumin. 
D) Representative HEp2 slides incubated with sera from 8–15 week-old Faslpr/lpr (positive 
control), Lcp2+/twp or Lcp2twp/twp mice, followed by incubation with anti-mouse IgG-FITC. 
Bar graph indicates the proportion of 8–15 week-old autoantibody-positive Lcp2+/twp or 
Lcp2twp/twp mice. E) Representative flow cytometry plots (top) and frequencies (bottom) of 
IFN-γ, IL-4 or IL-17 expression in CD4+ and CD8+ splenocytes 4h after stimulation with 
PMA and ionomycin. Symbols represent individual mice, while bars represent mean and 
standard error. P values were calculated by Mann-Whitney test (A & B [IgE], C [total IgE 
naive], D) or 2-tailed unpaired Student’s t-test (A, B, C, E).
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Figure 4. Negative selection in Lcp2twp/twp mice
A) Percentages of CD4+ and CD8+ peripheral blood lymphocytes that were Vβ11+ or Vβ5+ 
were compared between H2b and H2k genetic backgrounds. B) Thymocytes and splenocytes 
from 3A9 TCR transgenic (TCR+) or 3A9 TCR;mHEL double transgenic (TCR+mHEL+) 
mice were analysed by flow cytometry, and absolute numbers of DN (CD4−CD8−), DP 
(CD4+CD8+), CD4SP (CD4+CD8−) and CD4+1G12+) were calculated (C). D) Flow 
cytometry of CD24+Foxp3− thymocytes from wild-type, Lcp2twp/twp or Zap70mrd/mrt mice 
showing a gate for the TCRβ+ subset (top), amongst which the frequency of Helios+ cells 
was enumerated (bottom). E) Frequencies of the indicated populations were calculated from 
the histograms presented in (D). Symbols represent individual mice, while bars represent 
mean and standard error. P values were calculated by 2-tailed unpaired Student’s t-test.
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Figure 5. Development of Foxp3+ cells in Lcp2twp/twp mice
Representative flow cytometry plots and absolute numbers of CD4+Foxp3+ thymocytes (A) 
or splenocytes (B). C) Representative histogram overlays of CD25 and GITR expression 
upon CD4+Foxp3+ splenic lymphocytes from Lcp2+/+ (filled) and Lcp2twp/twp (open) mice. 
Symbols represent individual mice, while bars represent mean and standard error. P values 
were calculated by 2-tailed unpaired Student’s t-test.
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Figure 6. Impaired function of Lcp2twp/twp Foxp3+ cells
A) Proliferation of FACS-purified CD4+CD44loCD62LhiCD25− responders (CD45.1), after 
68 hours of stimulation with soluble anti-CD3. Responders were cultured in the presence of 
FACS-purified CD3−CD4−CD8− cells (APCs, C57BL/6, CD45.2) and CD4+GFP+ cells (T-
regs, CD45.2) from Lcp2+/+ or Lcp2twp/twp Foxp3gfp mice. (B) Flow cytometry plots from 
experiment 2 (T-reg:APC ratio of 2−2).
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Figure 7. Correction of Lcp2twp/twp serological phenotypes by adoptive transfer of Lcp2+/+ 
splenocytes
A) 1–4 week-old Lcp2twp/twp mice received intraperitoneal injections of ~3×107 whole 
splenocytes from Lcp2+/+ donors (Lcp2twp/twp (+/+ i.p.)), or did not receive any donor 
splenocytes (Lcp2twp/twp, Lcp2+/+). Recipients were sacrificed 5 weeks post-transfer and 
serum was assayed for the presence of IgE and IgG1 antibodies. (B,C) CD45.2+ Lcp2twp/twp 
mice aged 6–11 weeks were left unmanipulated or were injected i.v. with ~2×107 
splenocytes from CD45.1+ Foxp3+/y or Foxp3−/y littermate mice aged 2–3 weeks. Peripheral 
blood was collected 3–6 weeks after adoptive transfer and serum IgE concentration was 
measured by ELISA (shown in B) and is plotted as a function of the frequency of CD45.1+ 
donor cells amongst CD4+ cells (in C). D) Foxp3−/Y mice (CD45.1) were injected 
intraperitoneally at 1 or 7 days of age with 1.25–2 × 105 FACS-sorted GFP+ splenocytes 
from Lcp2+/+ or Lcp2twp/twp Foxp3gfp donors (CD45.2), with donor CD4+ engraftment 
measured at 19 or 28 days of age. Results are pooled from two independent experiments. 
Symbols represent individual mice, while bars represent mean and standard error. P values 
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were calculated by a Kruskal-Wallis test followed by Dunn’s multiple comparison test (A 
[IgE]), or one-way ANOVA followed by Bonferroni’s multiple comparison test (A [IgG1]).
Siggs et al. Page 21
J Immunol. Author manuscript; available in PMC 2015 September 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
